Selective control of gene expression by CDK9 in human cells
Judit Garriga1, Hongbo Xie, Zoran Obradovic
1Fels Institute for Cancer Research and Molecular Biology, Philadelphia, Pennsylvania 19140, USA.
Journal of Cellular Physiology
|September 26, 2009
Summary
Cyclin-dependent kinase 9 (CDK9) regulates gene transcription. Inhibiting CDK9 directly impacts gene expression uniquely, affecting specific gene subsets rather than global transcription, unlike flavopiridol.
Area of Science:
- Molecular Biology
- Gene Regulation
- Biochemistry
Background:
- Cyclin-dependent kinase 9 (CDK9) is known to regulate transcriptional elongation.
- Its precise role in global gene expression, whether broad or gene-specific, remains unclear.
- Flavopiridol (FVP) is a CDK inhibitor used to study CDK9's function.
Purpose of the Study:
- To investigate the direct effects of CDK9 inhibition on global gene expression in human cells.
- To compare the effects of direct CDK9 inhibition with pharmacological inhibition using FVP.
- To elucidate the specific role of CDK9 in gene transcription regulation.
Main Methods:
- Utilized a dominant-negative form of CDK9 (dnCDK9) to inhibit cellular CDK9 activity.
- Employed DNA microarray analysis to assess global gene expression changes.
- Compared gene expression profiles resulting from dnCDK9 treatment and FVP treatment.
Main Results:
- Direct CDK9 inhibition with dnCDK9 resulted in a distinct gene expression pattern, upregulating 122 genes and downregulating 84.
- FVP treatment showed global transcriptional inhibition, affecting short-lived transcripts differently than dnCDK9.
- A significant overlap in gene modulation trends was observed between dnCDK9 and FVP treatments, suggesting shared pathways.
Conclusions:
- The potent transcriptional effects of FVP may involve inhibition of additional CTD kinases beyond CDK9.
- CDK9 plays a complex and gene-specific role in modulating gene expression.
- Direct inhibition of CDK9 reveals a more nuanced regulatory role than previously inferred from FVP studies.
Related Concept Videos
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
01:45Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...